Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Urinary Bladder Neoplasms 2Urologic Neoplasms 1Neurofibromatoses 1Neoplasms 1Hydrocephalus 1Headache 1Glycopyrrolate 1Epilepsy 1Abdominal Neoplasms 1

Interventions

mirdametinib 3Imatinib Mesylate 3Surveys and Questionnaires 2tipifarnib 1talimogene laherparepvec 1pirfenidone 1nilotinib 1emvododstat 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1Sunitinib 1Sirolimus 1Sevoflurane 1Propofol 1Percutaneous Collagen Induction 1Nitrous Oxide 1Magnetic Resonance Spectroscopy 1Lidocaine 1Lasers, Solid-State 1Lasers 1Glycopyrrolate 1Dexmedetomidine 1Blood Specimen Collection 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatoses × Glycopyrrolate × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡